Retrospective Study
Copyright ©The Author(s) 2024.
World J Diabetes. Apr 15, 2024; 15(4): 654-663
Published online Apr 15, 2024. doi: 10.4239/wjd.v15.i4.654
Table 1 Differences in clinical data between the neovascular glaucoma and No- neovascular glaucoma-groups
Data
NVG group (n = 21)
No-NVG group (n = 130)
χ2/t
P value
Sex, n (%)Male12 (57.14)78 (60.00)0.0610.084
Female9 (42.86)52 (40.00)
Age (mean ± SD, yr)57.58 ± 8.1255.21 ± 10.271.0070.315
BMI (mean ± SD, kg/m2)22.28 ± 3.1622.24 ± 3.410.0500.959
Diabetes duration (mean ± SD, yr)10.23 ± 3.1110.37 ± 3.460.1740.861
Diabetes type, n (%)Type 14 (19.05)11 (8.46)1.2360.266
Type 217 (80.95)119 (91.54)
DR severityNonproliferative8 (38.10)64 (49.23)0.8990.343
Proliferative13 (61.90)66 (50.77)
Complicated with hypertension, n (%)Yes14 (66.67)59 (45.38)3.2790.070
No7 (33.33)71 (54.62)
Combined hyperlipidemia, n (%)Yes13 (61.90)61 (46.92)1.6240.203
No8 (38.10)69 (53.08)
Preoperative intraocular pressure (mean ± SD, mmHg)15.23 ± 2.8115.26 ± 2.870.0440.964
Operation time (mean ± SD, min)125.42 ± 16.85120.13 ± 15.731.4160.158
Intraocular pressure 7 d after surgery (mean ± SD, mmHg)19.15 ± 2.2518.16 ± 2.411.7620.080
Number of vitrectomies, n (%)First time15 (71.43)110 (84.62)2.2060.138
Not the first time6 (28.57)20 (15.38)
Intraocular filler, n (%)Silicone oil3 (14.29)38 (29.23)1.3560.244
BSS or gas fill18 (85.71)92 (70.77)
Combined cataract surgery, n (%)Yes12 (57.14)52 (40.0)2.1760.140
No9 (42.86)78 (60.0)
Posterior capsular integrity in combined cataract surgery, n (%)Complete15 (71.43)128 (98.46)6.441< 0.001
Defect6 (28.57)12 (9.23)
Ipilateral carotid artery stenosis ≤ 25.0%, n (%)Yes4 (19.05)6 (4.62)6.090< 0.001
No17 (80.95)124 (95.38)
Residual retinal non-perfusion area, n (%)Yes7 (33.33)17 (13.08)5.549< 0.001
No14 (66.67)113 (86.92)
Preoperative anti-VEGF drug therapy, n (%)Yes3 (14.29)42 (32.31)2.0120.156
No18 (85.71)88 (67.69)
Preoperative VEGF (mean ± SD, pg/mL)312.01 ± 29.29275.64 ± 36.924.297< 0.001
HbA1C (mean ± SD, %)9.31 ± 1.298.42 ± 1.073.434< 0.001
Serum IL-6 (mean ± SD, pg/mL)3.51 ± 0.673.15 ± 0.851.8480.066
Serum IL-10 (mean ± SD, pg/mL)2.62 ± 0.422.74 ± 0.570.9230.357
Serum TNF-α (mean ± SD, pg/mL)10.88 ± 3.419.52 ± 3.061.8600.064
Aqueous IL-6 (mean ± SD, pg/mL)54.54 ± 15.8139.14 ± 11.105.526< 0.001
Aqueous IL-10 (mean ± SD, pg/mL)9.91 ± 2.777.94 ± 1.924.067< 0.001
Aqueous TNF-α (mean ± SD, pg/mL)5.00 ± 1.263.91 ± 0.755.499< 0.001